1. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet. 1998. 351:659–664.
2. Yamazaki K, Yamazaki T, Masumoto J, Suzuki A, Yazaki M, Agematsu K. Familial Mediterranean fever as representative autoinflammatory disease. Rinsho Byori. 2009. 57:371–381.
3. Tsuchiya-Suzuki A, Yazaki M, Nakamura A, Yamazaki K, Agematsu K, Matsuda M, Ikeda S. Clinical and genetic features of familial Mediterranean fever in Japan. J Rheumatol. 2009. 36:1671–1676.
4. Koo KY, Park SJ, Wang JY, Shin JI, Jeong HJ, Kim BJ, Lee JS. The first case of Familial Mediterranean Fever associated with renal amyloidosis in Korea. Yonsei Med J. 2012. 53:454–458.
5. French Familial Mediterranean Fever Consortium. A candidate gene for familial Mediterranean fever. Nat Genet. 1997. 17:25–31.
6. The International Familial Mediterranean Fever Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997. 90:797–807.
7. Bernot A, da Silva C, Petit JL, Cruaud C, Caloustian C, Castet V, Ahmed-Arab M, Dross C, Dupont M, Cattan D, et al. Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet. 1998. 7:1317–1325.
8. Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-Wolf H, Livneh A, Pras M, Pras E. Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum. 2009. 60:1862–1866.
9. Booty MG, Chae JJ, Masters SL, Remmers EF, Barham B, Le JM, Barron KS, Holland SM, Kastner DL, Aksentijevich I. Familial Mediterranean fever with a single MEFV mutation: Where is the second hit? Arthritis Rheum. 2009. 60:1851–1861.
10. Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-Wolf H, Livneh A, Pras M, Pras E. Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum. 2009. 60:1862–1866.
11. Tchernitchko D, Legendre M, Cazeneuve C, Delahaye A, Niel F, Amselem S. The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever. Hum Mutat. 2003. 22:339–340.
12. Topaloglu R, Ozaltin F, Yilmaz E, Ozen S, Balci B, Besbas N, Bakkaloglu A. E148Q is a disease-causing MEFV mutation: a phenotypic evaluation in patients with familial Mediterranean fever. Ann Rheum Dis. 2005. 64:750–752.
13. Touitou I. The spectrum of familial Mediterranean fever mutations. Eur J Hum Genet. 2001. 9:473–483.
14. Drenth JP, Haagsma CJ, vanderMeer JW. International Hyper-IgD Study Group. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. Medicine (Baltimore). 1994. 73:133–144.
15. Medlej-Hashim M, Petit I, Adib S, Chouery E, Salem N, Delague V, Rawashdeh M, Mansour I, Lefranc G, Naman R, et al. Familial Mediterranean fever: association of elevated IgD plasma levels with specific MEFV mutations. Eur J Hum Genet. 2001. 9:849–854.
16. Aksu G, Ozturk C, Kavakli K, Genel F, Kutukculer N. Hypercoagulability: interaction between inflammation and coagulation in familial Mediterranean fever. Clin Rheumatol. 2007. 26:366–370.
17. Ruiz XD, Gadea CM. Familial Mediterranean fever presenting with pulmonary embolism. Conn Med. 2011. 75:17–19.
18. Standing AS, Eleftheriou D, Lachmann HJ, Brogan PA. Familial Mediterranean fever caused by homozygous E148Q mutation complicated by Budd-Chiari syndrome and polyarteritis nodosa. Rheumatology. 2011. 50:624–626.
19. Kwon SR, Lim MJ, Park SG, Moon YS, Park W. Decreased protein S activity is related to the disease activity of Behcet's disease. Rheumatol Int. 2006. 27:39–43.